©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Syk Mutation in Jurkat E6-derived Clones Results in Lack of p72 Expression (*)

(Received for publication, July 26, 1995; and in revised form, September 1, 1995)

Joseph Fargnoli (1) Anne L. Burkhardt (1) Maureen Laverty (1) Stephanie A. Kut (1) Nicolai S. C. van Oers (2) Arthur Weiss (2) Joseph B. Bolen (3)(§)

From the  (1)Department of Oncology, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543, the (2)Howard Hughes Medical Institute, Department of Medicine, and Department of Microbiology and Immunology, University of California, San Francisco, California 94066, and the (3)Department of Cellular Signaling, DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, California 94304

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES

ABSTRACT

The human leukemic Jurkat cell line is commonly used as a model cellular system to study T lymphocyte signal transduction. Various clonal derivatives of Jurkat T cells exist which display different characteristics with regard to responses to external stimuli. Among these, the E6-1 clone of Jurkat T cells has been used as a parental line from which numerous important somatic mutant clones have been generated. During the course of experiments examining signals initiated by the T cell antigen receptor in an E6-1-derived Jurkat cell clone J.CaM1, we observed that the 72-kilodalton Syk protein tyrosine kinase previously found in other Jurkat cells was not detected. Upon further analysis it was determined that Syk transcripts from the J.CaM1 cells as well as the parental E6-1 cells contain a single guanine nucleotide insertion at position 92. This nucleotide insertion results in a shift in the Syk open reading frame leading to alternate codon usage as well as the generation of a termination codon at position 109. Thus, Syk transcripts in E6-1 cells and E6-1-derived clones are predicted to be capable of encoding only the first 33 amino acids of the 630-amino acid wild type Syk. These findings are incompatible with a recently proposed model of T cell antigen receptor signal transduction based, in part, on experiments conducted using E6-1-derived cells, suggesting that Syk might play a role upstream of Lck and Zap70.


INTRODUCTION

The Syk protein tyrosine kinase together with the Zap70 protein tyrosine kinase comprise a family of cytoplasmic enzymes that are important for signal transduction initiated by different types of surface receptors in cells of hemopoietic origin(1) . Unlike other cytoplasmic protein tyrosine kinases, Syk and Zap70 possess tandem SH2 domains amino-terminal to their catalytic domain(2, 3) . The Syk and Zap70 SH2 domains serve to bind tandem phosphotyrosine containing elements in the membrane-associated signal coupling subunits of immune recognition receptors(1) . These 18-20 amino acid elements are referred to as immunoreceptor tyrosine activation motifs and have the consensus sequence (D/E)XXYXX(I/L)XYXX(I/L) (4) . Association of Syk and Zap70 with the phosphorylated immunoreceptor tyrosine activation motifs serves to position the kinases in a membrane proximal location and contributes to the activation of the enzymes(5, 6, 7, 8, 9, 10) .

Zap70 is expressed in all major thymocyte populations as well as in mature T cells of both CD4 and CD8 lineages(11) . Syk too is expressed in all of the major thymocyte populations although the levels of Syk diminish severalfold in peripheral T lymphocytes(11) . Syk is also expressed in an additional number of hemopoietic cells including B cells(11, 12) , mast cells(13, 14) , neutrophils(15) , macrophages(16) , erythroid cells(17) , and platelets(18) . Current evidence suggests that Zap70 and Syk may potentially contribute in distinct ways to signal transduction events in T cells and thymocytes. Patients with mutations in the ZAP gene demonstrate abnormal development of thymocytes leading to the production of exclusively CD4 T cells in the periphery(19, 20, 21) . These T cells are, however, unresponsive to mitogen and antigen stimulation(19, 20, 21) . While no SYK mutations have been documented in humans, targeted disruption of the syk gene in mice has been shown to block B cell but not T cell developmental pathways(22) .

Much of our understanding of the signaling events initiated following the surface engagement of the T cell antigen receptor (TcR) (^1)has been based upon model cell systems. One of the most useful and widely studied of these T cell models has been the human T cell leukemia line Jurkat. Indeed, Zap70 was initially identified as a TcR subunit-associated protein and molecularly cloned from Jurkat T cells(2, 23) . Previous studies have demonstrated that Jurkat T cells express both Syk and Zap70(8, 11) . Following TcR cross-linking both Syk and Zap70 were found to be enzymatically activated in a temporally indistinguishable manner (8) and both were found to be capable of association with the TcR subunit(8, 11) . During the course of experiments examining protein tyrosine kinase signaling in the J.CaM1 somatic cell mutant isolated from the Jurkat E6-1 line(24) , we noticed that the 72-kDa Syk protein tyrosine kinase was not readily detected. On further analysis it was found that J.CaM1, the parental Jurkat E6-1 line, as well as another E6-1-derived cell line J45.01(25) , express Syk transcripts containing a single guanine nucleotide insertion at position 92 which results in a frameshift leading to premature termination of the Syk open reading frame at position 109. In contrast, all Syk transcripts from other Jurkat lines in which p72 was readily detected were found to encode wild type Syk. These results demonstrate that functional Syk is not expressed in all Jurkat T cell-derived clones.


MATERIALS AND METHODS

Cells

Jurkat E6-1 is a clone derived from Jurkat-FHCRC(26) . J.CaM1 (for Jurkat-derived Ca mutant 1) is a derivative of E6-1 isolated following ethyl methanesulfonate treatment(24) . J45.01 is a CD45-deficient clone derived from the E6-1 clone following irradiation and anti-CD45 plus complement-mediated selection(25) . H33HJ-JA1 Jurkat cells were purchased from ATCC. Other Jurkat cells were obtained from Ivan D. Horak (National Cancer Institute), Gerald R. Crabtree (Stanford University), and Michel Nussenzweig (Rockefeller University). All Jurkat cells were propagated in RPMI 1640 supplemented with 10% fetal bovine serum.

Antibodies

Rabbit antisera directed against Syk amino acids 260-370 and Zap70 amino acids 255-345 have been previously described (8) . Antisera against Syk amino acids 1-370 were produced by immunizing rabbits with the gluathione S-transferase-Syk fusion protein (Pharmacia Biotech Inc.).

Biochemical Analyses

Cell lysis, Syk and Zap70 immunoprecipitation, immune-complex kinase assays, and immunoblotting have all been previously described(8) .

RNA Isolation and Northern Analysis

Total RNA was isolated on an ABI 341 GENEPURE automated extractor (Perkin Elmer Corp.) and used directly for PCR or enriched for polyadenylated RNA by two cycles of oligo(dT) chromatography on prepoured columns according to the manufacturer's recommendations (Life Technologies). Radiolabeled cDNA probes corresponding to the entire open reading frame of human Syk or chicken beta-actin (27) were generated using [alpha-P]dCTP (3000 Ci/mmol, DuPont NEN) and the RadPrime Labeling System (Life Technologies). Ten micrograms of enriched polyadenylated RNA was used for Northern analysis by fractionation on 1.1% agarose gels and transferred to Hybond N nitrocellulose (Amersham) using 10 times SSC (1.5 M sodium chloride, 0.15 M sodium citrate). Hybridization and wash conditions were carried out under high stringency conditions according to Sambrook et al.(28) .

PCR Cloning and Sequencing

Five micrograms of total RNA was reverse transcribed with random hexamers (1 µl of 100 ng/µl/reaction) using Superscript II reverse transcriptase according to the manufacturer's recommendations (Life Technologies). Five microliters of the reverse transcription reactions were used for PCR with Hot Tub polymerase (Amersham) using primers with homology to various positions in the Syk cDNA as indicated in the text. For PCR of the internal DNA fragments surrounding the mutation site, 35 cycles of a 20-s denaturation step at 94 °C, an annealing step at 55 °C for 20 s, and an extension for 40 s at 70 °C was used. For PCR of the entire open reading frame, two-step PCR (29) was employed using 35 cycles with an 4-s denaturation step at 94 °C and an 6-min extension at 70 °C. In all cases PCR products were gel isolated using Glass Max columns (Life Technologies) and subcloned into the PCRll vector using the TA Cloning kit from Invitrogen. All clones were sequenced using the ABI 373 DNA Sequencer and the AmpliTaq Sequencing kit (Perkin Elmer, Norwalk, CT).

In Vitro Transcription and Translation

Plasmids containing the entire open reading frame of the Syk cDNA sequence were isolated and purified using Qiagen tip-20 columns (QIAGEN, Inc., Chatsworth, CA). One µg of plasmid DNA was used for coupled transcription/translation with SP6 or T7 polymerase using the TNT Coupled Reticulocyte Lysate system according to the manufacturer's protocols (Promega Inc.).


RESULTS

Lack of Detectable p72in E6-1-derived Jurkat Cells

Representative Jurkat lines were examined for the expression of Zap70 and Syk by specific enzyme immunoprecipitation followed by immunoblot analysis. As shown in Fig. 1(left panel), all of the Jurkat lines were found to express approximately equivalent amounts of Zap70. The results shown in Fig. 1(right panel) demonstrate that p72 expression was not detected in the E6-1 Jurkat clone nor in the E6-1-derived J.CaM1 clone while Syk was easily detected in the H33HJ Jurkat clone as well as all other non-E6-1-derived Jurkat cells we have tested (data not shown). We also failed to detect Syk expression in the E6-1-derived J45.01 clone (data not shown). In other experiments, we found that Syk was not detected by immunoblotting in the E6-1, J.CaM1, or J45.01 cells using other Syk antisera directed to different portions of the enzyme nor did we detect Syk by measuring autophosphorylating activity in immune complex protein kinases assays (data not shown). Furthermore, we failed to detect Syk activity or protein expression following TcR cross-linking in the E6-1-derived cell lines (data not shown). These results indicate that the Syk protein is not expressed prior to or following TcR mediated activation in the E6-1-derived cell lines.


Figure 1: Expression of p70 and p72 in Jurkat cell clones. Detergent lysates of the indicated Jurkat clones were adjusted to 1 mg/reaction and immunoprecipitation and immunoblot analysis of either Zap70 (left panel) or Syk (right panel) performed. The lane marked C in each panel represents H33HJ lysates immunoprecipitated with preimmune rabbit sera. The positions of prestained molecular mass markers in kilodaltons (Life Technologies, Inc.) are indicated.



Detection of Syk Transcripts in E6-1-derived Jurkat Cells

Poly(A) RNA was isolated from the various Jurkat cell lines and Northern analysis was performed to determine if Syk mRNAs were expressed. The results of this experiment (Fig. 2, upper panel) demonstrate that similar levels of the major Syk transcript of approximately 2.8 kilobase pairs as well as minor Syk RNA species were detected in all of the Jurkat cell lines examined. Thus, the absence of detectable Syk protein could not be explained by alterations in the abundance of Syk mRNA.


Figure 2: Northern blot analysis of Syk transcripts in Jurkat cell clones. Ten µg of poly(A) RNA isolated from the indicated Jurkat cell clones was analyzed using a full-length Syk cDNA (upper panel) or beta-actin (lower panel) probe. The positions of RNA molecular size markers (Life Technologies, Inc.) in kilobases are shown on the right while the positions of 28 S and 18 S ribosomal RNAs are shown on the left of each panel.



Molecular Cloning and Analysis of Syk cDNAs

The results of the preceding experiments raised the possibility that the open reading frame of Syk expressed in E6-1-derived cells might contain some type of mutation that prohibited stable protein production. To explore this possibility Syk cDNAs were isolated, cloned, and sequenced from representative E6-1 and non-E6-1 Jurkat backgrounds. As shown in Fig. 3and documented further in Table 1, all of the full-length Syk cDNA clones isolated from E6-1 lineage Jurkats were found to contain a single guanine nucleotide insertion at position 92, while the Syk cDNA sequences from non-E6-1 Jurkats were found to be identical to the wild type Syk(30) . Additional partial cDNAs which included the portion containing the single nucleotide insertion were also independently isolated and sequenced. The results of these studies (Table 1) confirmed that E6-1-derived Jurkats contain Syk transcripts with an additional guanine at position 92.


Figure 3: Syk nucleotide sequence and deduced amino acid sequences from Jurkat cell clones. The nucleotide sequence derived from representative cDNAs from H33HJ (J) and E6-1 (E6) Jurkat cell clones are indicated. The corresponding amino acids predicted from the cDNA sequences are given below the nucleotide sequences with the H33HJ amino acid sequences above those predicted for the E6-1 amino acid sequences. The numbers on the left refer to nucleotide positions within the open reading frame. The Syk sequence derived from the H33HJ cells is the same as that previously determined from cDNAs isolated from Daudi Burkitt's lymphoma cells(30) .





The consequence of the guanine insertion at position 92 predicts that the Syk open reading frame should be shifted and undergo premature termination at position 109 allowing for the potential production of an Syk peptide of only 35 amino acids. This severely truncated gene product would not be detectable with our Syk antisera. In keeping with this prediction, the results shown in Fig. 4demonstrate that transcription/translation of the Syk open reading frame from the E6-1-derived cells failed to produce a detectable Syk protein while the Syk open reading frame obtained from non-E6-1-derived Jurkats produced the expected 72-kDa Syk protein.


Figure 4: Transcription/translation of cDNAs derived from Jurkat cell clones. One µg of plasmid DNA from the indicated Jurkat cell clones was used for transcription/translation in TNT-coupled rabbit reticulocyte lysates. The translation products were diluted in cell lysis buffer, immunoprecipitated with anti-Syk, and immune-complex protein kinase assays conducted. The positions of p72 (Syk) and prestained molecular mass markers are indicated.




DISCUSSION

The results presented in this report demonstrate that Jurkat cell clones derived from the Jurkat E6-1 clone fail to detectably express a functional Syk protein tyrosine kinase. The absence of detectable Syk in these cells is at least in part the consequence of a guanine nucleotide insertion at position 92 in the Syk open reading frame. The resulting frameshift allows for alternative usage of two codons before directing the premature termination of the open reading frame at position 109. The mutated Syk open reading frame allows for the predicted translation of the first 33 amino acids of Syk followed by histidine and glutamic acid prior to termination. While it is as yet unclear whether this predicted Syk amino-terminal peptide is expressed in the E6-1-derived cells, it is not anticipated that this peptide would be capable of any function ascribed to Syk since it would contain only the first 19 amino acids of the amino-terminal SH2 domain.

We have not analyzed the SYK genomic sequences corresponding to the mutation site observed in the Syk cDNAs isolated from the E6-1-derived cells. Therefore, it is not as yet determined if the nucleotide insertion is located in one or both SYK alleles. While all of the E6-1-derived Syk cDNAs isolated contained the mutation, we have detected very low levels of Syk in some E6-1-derived cells on rare occasions. Thus, our data is most compatible with the idea that a single SYK allele containing this mutation is predominantly expressed in these cells and that the other allele is transcriptionally impaired.

The lack of Syk expression in the E6-1 Jurkat cells does not appear to significantly alter the TcR-mediated responses of these cells when compared with Jurkat clones expressing Syk and Zap70. However, we cannot rule out that the absence of Syk in other E6-1-derived Jurkat clones might influence their signaling properties. The absence of Syk expression in E6-1 cells in fact may have facilitated the initial identification and characterization of Zap70 as the major -associated protein (2, 23) since Syk would have also been found associated with in Jurkat clones capable of expressing both Syk and Zap70(8, 11) . Moreover, these results, together with those obtained with mice deficient in Syk expression (22) as well as other studies analyzing E6-1 Jurkat signaling(2, 3, 7, 11, 23, 24, 25) , argue against a previously proposed model placing Syk upstream of Lck and Zap70(31, 32) .


FOOTNOTES

*
This work was supported in part by National Institutes of Health Grant GM39553 (to A. W.). The DNAX Research Institute is supported by Schering-Plough Corp. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
To whom correspondence should be addressed: DNAX Research Institute of Molecular and Cellular Biology, 901 California Ave., Palo Alto, CA 94304. Tel.: 415-852-9196; Fax: 415-496-1200.

(^1)
The abbreviations used are: TcR, T cell antigen receptor; PCR, polymerase chain reaction; SH2, src homology 2.


REFERENCES

  1. Weiss, A., and Littman, D. R. (1994) Cell 76, 263-274 [Medline] [Order article via Infotrieve]
  2. Chan, A. C., Iwashima, M., Turck, C., and Weiss, A. (1992) Cell 71, 649-662 [Medline] [Order article via Infotrieve]
  3. Taniguchi, T., Kobayashi, T., Kondo, J., Takahashi, K, Nakamura, H., Suzuki, J., Nagai, K., Yamada, T., Kadamura, S., and Yamaura, H. (1991) J. Biol. Chem. 266, 15790-15796 [Abstract/Free Full Text]
  4. Reth, M. (1992) Nature 338, 383-384
  5. Romeo, C., Amiot, M., and Seed, B. (1992) Cell 68, 889-897 [Medline] [Order article via Infotrieve]
  6. Irving, B. A., Chan, A. C., and Weiss, A. (1993) J. Exp. Med. 177, 1093-1103 [Abstract]
  7. Iwashima, M., Irving, B. A., van Oers, N. S. C., Chan, A. C., and Weiss, A. (1993) Science 263, 1136-1139
  8. Burkhardt, A. L., Stealey, B., Rowley, R. B., Mahajan, S., Prendergast, M., Fargnoli, J., and Bolen, J. B. (1994) J. Biol. Chem. 269, 23642-23647 [Abstract/Free Full Text]
  9. Rowley, R. B., Burkhardt, A. L., Chao, H.-G., Matsueda, G. R., and Bolen, J. B. (1995) J. Biol. Chem. 270, 11590-11594 [Abstract/Free Full Text]
  10. Shiue, L., Zoller, M. J., and Brugge, J. S. (1995) J. Biol. Chem. 270, 10498-10502 [Abstract/Free Full Text]
  11. Chan, A. C., van Oers, N. S. C., Tran, A., Turka, L., Law, C.-L., Ryan, J. C., Clark, E. A., and Weiss, A. (1994) J. Immunol. 152, 4758-4766 [Abstract/Free Full Text]
  12. Hutchcroft, J. E., Harrison, M. L., and Geahlen, R. L. (1992) J. Biol. Chem. 267, 8613-8619 [Abstract/Free Full Text]
  13. Benhamou, M., Ryba, N. J., Kihara, H., Nishikata, H., and Siraganian, R. P. (1993) J. Biol. Chem. 268, 23318-23324 [Abstract/Free Full Text]
  14. Rowley, R. B., Bolen, J. B., and Fargnoli, J. (1995) J. Biol. Chem. 270, 12659-12663 [Abstract/Free Full Text]
  15. Corey, S. J., Burkhardt, A. L., Bolen, J. B., Geahlen, R. L., Tkatch, L. S., and Tweardy, D. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 4683-4687 [Abstract]
  16. Darby, C., Geahlen, R. L., and Schreiber, A. D. (1994) J. Immunol. 152, 5429-5437 [Abstract/Free Full Text]
  17. Harrison, M. L., Isaacson, C. C., Burg, D. L., Geahlen, R. L., and Low, P. S. (1994) J. Biol. Chem. 269, 955-959 [Abstract/Free Full Text]
  18. Clark, E. A., Shattil, S. J., Ginsberg, M. H., Bolen, J. B., and Brugge, J. S. (1994) J. Biol. Chem. 269, 28859-28864 [Abstract/Free Full Text]
  19. Arpaia, E., Shahar, M., Dadi, H., Cohen, A., and Roifman, C. M. (1994) Cell 76, 947-958 [Medline] [Order article via Infotrieve]
  20. Elder, M. E., Lin, D. L., Clever, J., Chan, A. C., Hope, T. J., Weiss, A., and Parslow, T. (1994) Science 264, 1596-1599 [Medline] [Order article via Infotrieve]
  21. Chan, A. C., Kadlecek, T. A., Elder, M. E., Filipovich, A. H., Kuo, W.-L., Iwashima, M., Parslow, T. G., and Weiss, A. (1994) Science 264, 1599-1601 [Medline] [Order article via Infotrieve]
  22. Cheng, A. M., Rowley, R. B., Pao, W., Hayday, A., Bolen, J. B., and Pawson, T. (1995) Nature, in press
  23. Chan, A. C., Irving, B., Fraser, J. D., and Weiss, A. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 9166-9170 [Abstract]
  24. Goldsmith, M. A., and Weiss, A. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 6879-6883 [Abstract]
  25. Koretzky, G. A., Picus, J., Schultz, T., and Weiss, A. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 2037-2041 [Abstract]
  26. Weiss, A., Imboden, J., Shoback, D., and Stobo, J. (1984) Proc. Natl. Acad. Sci. U. S. A. 81, 4169-4173 [Abstract]
  27. Gunning, P., Ponte, P., Okayama, H., Engel, J., Blau, H., and Kedes, L. (1983) Mol. Cell. Biol. 3, 787-795 [Medline] [Order article via Infotrieve]
  28. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
  29. Kainz, P., Schmiedlechner, A., and Strack, H. B. (1992) Analytical Biochem. 202, 46-49 [Medline] [Order article via Infotrieve]
  30. Law, C.-L., Sidorenko, S. P., Chandran, K. A., Draves, K. E., Chan, A. C., Weiss, A., Edelhoff, S., Disteche, C. M., and Clark, E. A. (1994) J. Biol. Chem. 269, 12310-12319 [Abstract/Free Full Text]
  31. Couture, C., Baier, G., Altman, A., and Mustelin, T. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 5301-5305 [Abstract]
  32. Mustelin, T. (1994) Immunity 1, 351-356 [CrossRef][Medline] [Order article via Infotrieve]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.